16 results · 26ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Pruitt F3 Carotid Shunt, 10 Fr, Pruitt F3 Carotid Shunt, 9 Fr, Pruitt F3 Carotid Shunt, 8 Fr

FDA 510(k)
FDA Class 2 ·Cardiovascular

PRUITT F3 CAROTID SHUNT

FDA Adverse Event
Malfunction ·LEMAITRE VASCULAR, INC.·Product code MJN·May 21, 2021

PRUITT F3 CAROTID SHUNT

FDA Adverse Event
Injury ·LEMAITRE VASCULAR, INC.·Product code MJN·May 21, 2021

PRUITT F3 CAROTID SHUNT

FDA Adverse Event
Malfunction ·LEMAITRE VASCULAR, INC.·Product code MJN·May 21, 2021

PRUITT F3 CAROTID SHUNT

FDA Adverse Event
Malfunction ·LEMAITRE VASCULAR, INC.·Product code MJN·April 23, 2021

G-CATH TISSUE ANCHOR DELIVERY CATHETER

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

HRB-127-32 HIGH RESOLUTION BRAIN COIL

FDA 510(k)
FDA Class 2 ·Radiology

FUJIFILM ENDOSCOPE MODELS EC-760R-V/M

FDA Adverse Event
Malfunction ·FUJIFILM CORPORATION·Product code FDF·March 25, 2024

SYNCHROMED II

FDA Adverse Event
Injury ·MDT PUERTO RICO OPERATIONS CO·Product code LKK·June 21, 2013

COMPACT EXCHANGE DEVICE

FDA Adverse Event
Injury ·BAXTER HEALTHCARE - LARGO·Product code KDJ·July 28, 2011

G4 PLATINUM CONTINUOUS GLUCOSE MONITORING SYSTEM

FDA Adverse Event
Malfunction ·DEXCOM, INC.·Product code MDS·October 17, 2014

COMPREHENSIVE SHOULDER SYSTEM NANO HUMERAL COMP

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code HSD·September 26, 2023

COMPR NANO HMRL PPS 34MM

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code KWS·June 10, 2024

COMPREHENSIVE SHOULDER SYSTEM NANO NUMERAL COMPONENT 30 MM

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code HSD·March 21, 2024

St. Jude Medical CONFIRM Rx Insertable Cardiac Monitor, Sterile EO, Model #: DM3500 The Confirm Rx ICM is indicated for the monitoring and diagnostic evaluation of patients who experience unexplained symptoms such as: dizziness, palpitations, chest pain, syncope, and shortness of breath, as well as patients who are at risk for cardiac arrhythmias. It is also indicated for patients who have been previously diagnosed with atrial fibrillation or who are susceptible to developing atrial fibrillation.

FDA Enforcement
Class II ·Terminated·St Jude Medical Inc.·July 11, 2018

Boston Scientific COGNIS CRT-D, Cardiac Resynchronization Therapy Defibrillator, models N118, N119. The following models are not available in the US: models N106, N107, P106, P107. Sterilized using ethylene oxide. Product Usage: Boston Scientific cardiac resynchronization therapy defibrillators (CRT-Ds) are indicated for patients with moderate to severe heart failure who remain symptomatic despite stable, optimal heart failure drug therapy and have left ventricular dysfunction and QRS duration > or equal to 120 ms. This family of pulse generators provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Cardiac Resynchronization Therapy (CRT), which treats heart failure by resynchronizing ventricular contractions through biventricular electrical stimulation; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy.

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014